In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can ...
Dec 13, 2022
0
5
A new study has investigated the expression of the primary cilium in mesothelioma, finding that primary cilia is preferentially lost in the more aggressive subtype of mesothelioma and further research may confirm its potential ...
Oct 27, 2022
0
12
Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and ...
Aug 22, 2022
0
177
Mesotheliomas are very aggressive tumors, almost exclusively caused by asbestos, which are very often occupational. Between 2014 and 2020, four out of five cases of testicular mesothelioma assessed at an institute were recognized ...
Jun 23, 2022
0
1
From 1999 to 2020, there was an increase in the annual number of mesothelioma deaths among women, although the age-adjusted death rate decreased, according to research published in the May 13 issue of the U.S. Centers for ...
May 13, 2022
0
12
Researchers at the University of Colorado Anschutz Medical Campus and their international collaborators have discovered that a protein critical in the embryonic stages of life is reactivated in certain cases of mesothelioma, ...
Mar 30, 2022
0
114
Researchers have recently discovered that certain enzymes binded to each other may help lessen the risk of developing mesothelioma, a cancer of the lining of the lungs and abdomen. The study from University of Hawaiʻi Cancer ...
Dec 3, 2021
0
65
The PrE0505 phase 2 clinical trial results are published in the November 8 issue of Nature Medicine. The study evaluated the addition of durvalumab immunotherapy to standard chemotherapy in patients with previously untreated, ...
Nov 8, 2021
0
1
The monoclonal antibodies nivolumab and ipilimumab have already undergone several early benefit assessments in various oncological indications. Since April 2021, the drug combination has also been approved for first-line ...
Oct 4, 2021
0
0
A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found significant variability in access to care and a positive association between multimodality treatment, income levels, and survival ...
Sep 12, 2021
0
4
